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The advances of mass spectrometry in the analysis of nucleic acids have tracked very closely the
exciting developments of instrumentation and ancillary technologies, which have taken place over
the years. However, their diffusion in the broader life sciences community has been and will be
linked to the ever evolving focus of biomedical research and its changing demands. Before the
completion of the Human Genome Project, great emphasis was placed on sequencing technologies
that could help accomplish this project of exceptional scale. After the publication of the human
genome, the emphasis switched toward techniques dedicated to the exploration of sequences not
coding for actual protein products, which amount to the vast majority of transcribed elements. The
broad range of capabilities offered by mass spectrometry is rapidly advancing this platform to the
forefront of the technologies employed for the structure-function investigation of these noncoding
elements. Increasing focus on the characterization of functional assemblies and their specific
interactions has prompted a re-evaluation of what has been traditionally construed as nucleic acid
analysis by mass spectrometry. Inspired by the accelerating expansion of the broader field of
nucleic acid research, new applications to fundamental biological studies and drug discovery will
help redefine the evolving role of MS-analysis of nucleic acids in the post-genomics age. (J Am
SocMass Spectrom 2010, 21, 1–13) © 2010 Published by Elsevier Inc. on behalf of American Society
for Mass SpectrometryThe development of technologies for the analysisof nucleic acids by mass spectrometry (MS) hasfollowed step-by-step the evolution of the field,
with the introduction of electrospray ionization (ESI)
[1, 2] and matrix assisted laser desorption ionization
(MALDI) [3, 4] representing watershed events that
clearly delimit two different eras. Before the advent of
these ionization techniques, the realm of application
consisted mainly of the analysis of fundamental units
and components of limited size, such as nucleosides
(Figure 1) [5, 6], nucleotides [7, 8], and small oligonu-
cleotides [9–11], which often required derivatization of
their highly polar functional groups to increase volatil-
ity and to improve analytical performance. Overcoming
inherent technical challenges, this era established MS as
an irreplaceable tool for the characterization of rare
nucleotides produced by normal post-transcriptional
processes [12–14] and aberrant chemical damage [15–
17]. Efforts aimed at elucidating the building blocks of
these biopolymers culminated in the creation of a
comprehensive database of RNA modifications (avail-
able at http://library.med.utah.edu/RNAmods/) [18–
20], which today constitutes an invaluable resource for
the broader life sciences community. Proceeding for-
ward in this type of pursuit, MS-technologies continue
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[21–24].
Making Headways in Biomedical
Research
The introduction of ESI and MALDI made progres-
sively larger nucleic acids accessible to MS analysis
(Figure 2) [25–28], which ushered in a period of rapid
expansion into different areas of biomedical research.
The challenges posed by the larger analytes were an-
swered by the development of new strategies and
experimental methods (reviewed in references [29–33]),
which sought to take full advantage of favorable char-
acteristics exhibited by these ionization techniques,
such as their intrinsic low-energy and ability to handle
highly polar species. In the early 1990s, the rapid
advance of these technologies was largely fueled by the
demand for analytical platforms capable of affording
reliable and cost-effective DNA sequencing, which was
associated with the inception of the Human Genome
Project [34, 35]. Different approaches were devised to
obtain unambiguous sequence information through the
gas-phase dissociation of selected precursor ions in
MS/MS experiments [36–38], or the molecular mass
determination of ladder products obtained in solution
by terminating chain elongation [39–41], or inducing
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2 FABRIS J Am Soc Mass Spectrom 2010, 21, 1–13partial degradation of target sequences (Figure 3) [42–
44] (reviewed in references [45–47]). The expectations
were that high-throughput MS sequencing would play
a significant role in this project of unprecedented scale
by handling a fair share of the 3 billion base pair
genome. Additionally, the new approaches were ex-
pected to make MS the platform of choice for applica-
tions in medical diagnostics and for securing the infor-
mation necessary to implement personalized medicine.
By the mid-1990s, however, it was clear that such
approaches could not overtake the concomitant ad-
vances made by sequencing strategies based on electro-
phoresis [48–50], which were capable of handling
longer DNA segments, afforded greater multiplexing
capabilities, and were significantly less expensive [51].
In 1997, a well-publicized editorial conceded that com-
petitive MS technologies would not be ready to contrib-
Figure 1. Electron ionization-time of flight (EI-T
adenosine, and (d) deoxyadenosine. Samples wer
into the ionizing electron beam. Species of
corresponding mononucleotides, required deriv
reference [5], with permission.ute before the then-looming completion of the HumanGenome Project, but predicted that a bright future was
still in store for genotyping and diagnostic applications
[52]. This prediction was realized by the introduction of
technologies for the rapid characterization of single
nucleotide polymorphisms [53–55] and for the detec-
tion/identification of infectious pathogens [56–58]. At
the time of this editorial, however, the broader MS
community had been already shifting its attention to-
ward the burgeoning field of MS-based proteomics
[59–61].
Confronting New Challenges in the
Post-Genomics Era
The completion of the Human Genome Project has
brought to light surprising facts and posed new chal-
mass spectra of (a) uridine, (b) deoxyuridine, (c)
limed from the surface of a hot filament directly
er polar character, such as for example the
tion to enable vaporization. Reproduced fromOF)
e sub
great
atizalenges [62–64]. Its results have led to conservative
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be coding for actual proteins, in spite of the observation
that at least 70% of its sequence is transcribed into RNA
[65, 66]. Once upon a time dismissed as “selfish” or
“junk DNA” [67, 68], the intragenic (i.e., intronic) and
intergenic sequences representing the vast majority of
the transcribed pool are now undergoing extensive
re-evaluation. Indeed, the last decade has witnessed
resurgent interest in the elucidation of the functions of
noncoding elements (ncRNA) [69–71]. Although new
classes of functional RNA are being discovered on a
regular basis, their total amount still does not account
for the entire transcribed pool [72]. These discoveries
have keenly pointed out that sequence information
alone is not sufficient to reveal the function of all classes
of ncRNAs and to explain their mechanism of action.
This conclusion is substantiated, for example, by the
investigation of the activity of microRNAs (miRNAs)
and riboswitches, which are receiving a great deal of
attention for their participation in complex gene-regulation
networks. In the case of miRNAs [73, 74], their 22-
nucleotide sequence enables specific recognition of
mRNA targets in the cell [75], but the factors driving the
proper selection of cognate proteins to produce active
RNA-protein complexes (miRNPs) or determining
whether a certain miRNP may induce down- or up-
regulation of protein production remain to be eluci-
dated [76]. In the case of riboswitches [77, 78], expres-
sion of downstream gene(s) is modulated by
conformational changes induced by the interaction of a
specific cellular component (e.g., metabolite, metal ion,
etc.) with the 3D structure of the sensing domain, which
cannot be predicted or explained according to the
simple rules of base-pairing recognition [79, 80]. These
examples clearly highlight the need for technologies
capable of providing not only the higher-order struc-
ture of non-coding elements, but also unambiguous
information about the identity of cognate ligands, the
nature of their interactions, and the effects of binding on
structure and dynamics. Beyond its well-developed
sequencing capabilities, MS possesses unique strengths
Figure 2. MALDI-MS spectrum of a 461-nucleotide RNA tran-
script. The analysis was performed in positive ion mode after
removing the 5= phosphate by treatment with calf intestine phos-
phatase. The ability to handle larger nucleic acid analytes paved
the way for increasing applications in the life sciences. Repro-
duced from reference [25], with permission.that could advance this analytical platform to the forefrontof the technologies employed for the discovery and struc-
ture-function elucidation of noncoding nucleic acids.
The potential of MS-technologies for large scale
analysis of cellular RNAs has been demonstrated by the
implementation of fingerprinting strategies based on
endonuclease digestion of total tRNA extracts, followed
by MALDI-MS detection of signature products (Figure
4) [81, 82]. Analogous to approaches employed in
quantitative proteomics, 18O end-labeling by nuclease
digestion can be employed to evaluate RNA production
and observe possible variations in the amount of post-
transcriptionally modified nucleotides [83]. The devel-
opment of these types of approaches will be expected to
benefit the growing field of experimental RNomics by
complementing current technologies based on microar-
ray techniques and cDNA-based “deep sequencing,”
which can provide comprehensive views of entire cel-
lular transcriptomes [84, 85]. In fact, the dependence of
established technologies on amplification/sequencing
and electrophoretic analysis makes them ill-suited for
the detection of possible post-transcriptional modifica-
tions, which is likely the cause of our insufficient
understanding of the extent and biological significance
of ncRNA modifications. MS-based strategies for the
investigation of post-transcriptional modifications on a
full transcriptome scale, analogous to those available for
the identification of post-translational modifications of
proteins on a full proteome scale, could provide missing
information on the biological activities of noncoding ele-
ments and take their study in unexpected directions.
The most significant contributions to experimental
RNomics, however, could arguably arise from the avail-
ability of complementary ionization/desorption tech-
niques, which have pushed MS closer to becoming a
Figure 3. MALDI-MS spectrum of ladder products obtained by
digesting oligonucleotide V, 5=-d(GCTTXCTCGAGT), with the
3=-exonuclease snake venom phosphodiesterase; 2=-O-methyl-
adenosine is indicated by X. The mass difference between contig-
uous peaks corresponds to that of the cleaved nucleotide. Moni-
toring the progress of digestion reactions as a function of time
provided an effective way for tackling larger substrates by obtain-
ing partial overlapping snapshots of their entire sequences. Re-
produced from reference [42], with permission.
e [81
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virtually any type and origin. This uncanny flexibility
could be harnessed to achieve the characterization of
any ligand co-purified with a target nucleic acid of
interest, which could represent the constitutive ele-
ments of a putative functional assembly. To this effect,
affinity chromatography and related “pull-down” strat-
egies have been routinely employed to recognize cog-
nate proteins interacting with specific RNA [86] and
DNA [87] sequences (reviewed in references [88–90]).
Similar strategies could be readily adapted to identify
any type of biomolecule or small molecule ligand that
may be capable of binding a certain construct with
sufficient affinity, taking advantage of a growing num-
ber of metabolome databases for correct assignments
[91–94]. This type of scheme could represent an excellent
complement to microarray technologies involving the im-
Figure 4. MALDI-MS spectra obtained from to
(a) and (b), or RNase A (c). These experiments
products, or signatures, can provide the identific
pool of a certain cell. Reproduced from referencmobilization of specific RNA sequences covering the de-sired portion of the transcribed pool. Reversing the
terms of this experimental design, the ligand of interest
could be immobilized to enable the isolation of any
nucleic acid structure with specific binding activity,
thus leading to the identification of cognate sequences
that may be involved with the selected ligand in bio-
logically active assemblies. High-throughput schemes
could be implemented to perform systematic screening
of sequences capable of binding series of metabolites
involved in the same or parallel pathways, or represen-
tative compounds from selected classes of xenobiotics.
The potential in this direction is still largely untapped.
Elucidating Structure-Function Relationships
Mass spectrometry offers additional capabilities that
make it an invaluable platform for the study of the
coli tRNA after digestion with either RNase T1
nstrated that the detection of unique digestion
of individual isoacceptors present in the tRNA
], with permission.tal E.
demo
ationstructure-function relationships of these types of nu-
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known to date is associated with their ability to estab-
lish specific interactions with other cellular compo-
nents. Therefore, their elucidation places a premium on
the possibility of observing intact functional assemblies
and probing their salient structural features. The advent
of soft ionization techniques and the advances of ana-
lyzers design have made this possibility a reality. In-
deed, relatively short duplexes formed by complemen-
tary deoxyoligonucleotides were among the first
noncovalent complexes detected by ESI without unwel-
come dissociation [95–97]. Although this desirable out-
come can be obtained also by MALDI with a judicious
selection of matrix, additives, and other experimental
conditions [98–101], ESI remains the ionization tech-
nique of choice for the detection of nucleic acid nonco-
valent assemblies (reviewed in references [102–105]).
Direct ESI-MS analysis of nucleic acid complexes
with other nucleic acids [106–110], proteins [111–116],
and small molecule ligands [117–120] can reveal their
exact composition and stoichiometry from the observed
molecular mass, dispensing with the typical curve-
fitting of bulk data required by spectroscopic and
calorimetric methods. Unlike these techniques, MS is
capable of resolving any free/bound species at equilib-
rium in solution, even when such species possess very
similar spectroscopic characteristics. With proper ex-
perimental design and data treatment, their respective
signal intensities can be employed to obtain relative
Figure 5. (a) ESI-MS spectrum of an equimo
polypurine tract DNA:RNA hybrid duplex (PPT
and PPTRNA, respectively), and a duplex in w
swapped (PPTSWP). (b) ESI-MS spectrum obtaine
mitoxantrone. (c) ESI-MS spectrum after additio
PPTDNA, which was found capable of binding u
supported the binding of up to four units und
provided the following relative scale of binding
Reproduced from reference [134], with permission.[121, 122] and absolute [123–128] dissociation constants
(Kd’s) in solution, matching those afforded by estab-
lished methods [129]. In this direction, competitive
binding experiments in which multiple ligands are
mixed simultaneously with the substrate of interest
have proven very effective in providing relative scales
of binding affinities based on the aspect ratio and
distribution of the detected complexes [130–133]. Re-
versing the terms of the competition scheme, a ligand of
interest can be also added to multiple substrates simul-
taneously, for example, to directly compare the effects
of subtle variations in substrate structure on binding
mode (Figure 5) [134]. In more rigorous fashion, quan-
titative determinations of Kd can be accomplished by
following titration schemes in which the amount of
ligand is increased stepwise and the abundances of
free/bound species in solution are determined after
each addition [125–128]. Possible dissociative effects
induced by adding a certain ligand to a preformed
complex can be also assessed to obtain quantitative
determinations of inhibition constants (Ki’s) or ligand
concentrations inducing 50% dissociation of the initial
complex (IC50’s) [135]. It is expected that these ap-
proaches will become increasingly popular as desirable
features, such as limited sample consumption and ex-
emption from radio- or fluorescent-labeling, will be-
come better known within the broader life sciences
community.
In addition to information attainable by taking
ixture of substrates consisting of the HIV-1
ts DNA:DNA and RNA:RNA versions (PPTDNA
the wild type DNA and RNA sequences are
r addition of 1 equivalent of the anticancer drug
10 equivalents of ligand. With the exception of
five mitoxantrone units, all the other substrates
e selected experimental conditions. The results
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spectrometry can provide further insights into the na-
ture of the interactions involved in functional nucleic
acid assemblies by studying them in the gas-phase. The
dissociation of these species has been activated directly
in the ESI source [136–138], or after ion selection in
MS/MS experiments [139–141], to assess their stability
and to glean valuable details about determinant struc-
tural features [142–145]. For example, the dissociation
of duplex structures in the absence/presence of ligands
has been investigated to demonstrate the preservation
of Watson-Crick pairing and stacking interactions in the
gas phase and to elucidate the effects of selected binders
on the stability of these interactions [142–146]. Con-
versely, analogous experiments have been completed to
study the effects of ligand structure on binding mode
[110, 136, 147]. A great deal of effort has been dedicated
over the years to understand the fundamentals, to
conciliate gas-phase observations with solution behav-
iors, and to enable predictions of experimental outcome
from structural information and vice versa.
Finally, mass spectrometry can be also employed to
elucidate higher-order structures of nucleic acids and their
functional assemblies by following a variety of solution
and gas-phase approaches. Chemical footprinting and
bifunctional crosslinking have been combined with MS
analysis to reveal the position of base-pairing interactions,
which define elements of secondary structure of nucleic
acids, or to identify long-range contacts between discrete
domains, which outline tertiary structures and determine
the global fold of the larger species [148–151]. The spatial
constraints obtained by these approaches constitute valid
input for performing molecular modeling by established
computational methods, thus enabling the creation of
all-atom 3D models based on actual experimental data
(Figure 6) [152, 153]. Crosslinking strategies can also help
identify the contacts between nucleic acids and cognate
proteins [154–157] and reveal the organization of multi-
subunit functional complexes [158–160]. The possible ap-
plication of hydrogen/deuterium exchange (HDX) to
characterize the contact interfaces between assembled
units has been hampered by the fast exchange rate exhib-
ited in solution by the nucleic acid components [161, 162].
However, this approach has been successfully employed
to highlight the protein surfaces in contact with them and
to study the dynamics associated with the specific inter-
actions [163–165]. The implementation of HDX in the gas
phase has been demonstrated for nucleotides [166, 167],
unstructured oligonucleotides [168], and relatively small
structured constructs [169, 170], but its application to the
larger assemblies has yet to be reported.
Gas-phase approaches have been developed to map
ligand sites and to gain precious insights into the
architecture of large multi-subunit assemblies with nu-
cleic acid components. Under suitable activation condi-
tions, the binding of selected ligands to RNA substrates
can prevent underlying nucleotides from undergoing
the typical backbone fragmentation that produces the
characteristic ion series employed in MS/MS sequenc-ing. This observation has promoted strategies for
achieving the characterization of specific binding sites
onto target nucleic acid structures, which are revealed
by recognizable gaps in the detected ion series [134, 171,
172]. Conversely, the same protection effects can be
employed to screen libraries of small molecule ligands
for their ability to bind to desired structural motifs,
which is evaluated from their power to induce site-
directed inhibition of nucleic acid fragmentation [123,
173]. In the absence of covalent fragmentation, the order
by which bound subunits dissociate as discrete prod-
ucts may reveal their spatial situation within the com-
plex of interest. Indeed, submitting intact ribosomes and
their constitutive subunits to collisional activation induced
the progressive release of protein units according to their
affinity for each other and for the RNA components, but
also according to their placement relative to the surface of
the initial precursor ion [138, 174]. In similar fashion, the
dissociation of RNA-RNA pairing interactions was em-
ployed to interrogate the conformational state of assem-



























































































































Constraints map 3D structure
Figure 6. General workflow for 3D-structure determination of
nucleic acids based on structural probing and MS analysis
(MS3D). The substrate is probed under ideal conditions preserv-
ing its native fold. Characterization of the ensuing covalent
adducts can be performed under denaturing conditions, following
either bottom-up or top-down approaches. The positions of
probed nucleotides provide spatial constraints that are summa-
rized on 2D maps, from which a complete, all-atom 3D structure
can be readily generated through established molecular modeling
protocols.this example, the pattern afforded by collisional activa-
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assuming either a loop-loop kissing or an extended-
duplex conformation in the presence of their cognate
viral protein (Figure 7), which provided new insights
into the mechanism of structure remodeling mediated
by the chaperone protein. The conformational study of
progressively larger assemblies will be expected to take
full advantage of recent exciting developments in ion
mobility mass spectrometry, which has been already
shown to be capable of affording direct information
about nucleic acid structures in the gas phase [169, 176].
The Road Ahead
The unquestionable benefits offered by MS technologies
for nucleic acid analysis come with intrinsic challenges
posed by the very nature of these biomolecules. Some of
these challenges are general and apply to any analytical
platform, such as those concerning the integrity of RNA
samples, which require utilizing RNase-free solvents,
plastic ware, and tools to stave off rapid degradation.
Others are specific to the MS platform, such as those
originating from the presence of phosphate groups in
the biopolymer structure, which affect the selection of
sample preparation and mode of analysis. Indeed, the
negative charges afforded by these functional groups
confer nucleic acids a strong tendency to form un-
Figure 7. Collision-induced dissociation (CID
assembly folded in either extended-duplex or l
tively. Proteins are represented by circles, RNA
precursor ions. The extended-duplex complex d
loop-loop conformer underwent dissociation o
products. Adapted with permission from reference [wanted cation adducts that can deteriorate the attain-
able resolution and signal to noise ratio. Over the years,
alternative strategies have been devised to replace
metal cations with the more volatile ammonium [42,
177], which employ ion-exchange [178], reversed-phase
high-performance liquid chromatography [179], metal
chelation [180, 181], ethanol precipitation [177], ultrafiltra-
tion, and microdialysis [182–184]. Although separation-
based desalting is very effective for these types of biomol-
ecules, it may also result in the unwanted dissociation
of their noncovalent assemblies, either through exces-
sive reduction of the solution ionic strength, or through
direct perturbation of binding equilibria. In these cases,
a viable alternative consist of performing ion-ion reac-
tions with specific metal chelators, which can be accom-
plished in the gas phase after the desorption process is
complete and equilibrium considerations are no longer
a concern [185].
The presence of phosphate groups makes negative
ion mode the preferred mode of operation for the MS
analysis of nucleic acids. However, the sensitivity limits
achieved in this polarity appear to be consistently worse
than those afforded in the positive ion mode by the
same instrumentation/technique. While this practical
observation is well-known in the MS community, its
causes are still not understood. Addressing this discrep-
ancy will be critical for the direct analysis of cellular
ss spectra obtained from a 3:2 protein-RNA
loop kissing conformation, (a) and (b), respec-
nds by triangles. Squares mark the remaining
ed sequential loss of protein units, whereas the
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In the same direction, gas-phase activation techniques,
such as electron capture dissociation (ECD) [186] and
electron-transfer dissociation (ETD) [187], have been
extensively investigated for sequence analysis of pro-
teins and peptides in cationic form. However, the
exploration of equivalent methods for the activation of
anionic precursors and their application to nucleic acids
are still at a very early stage [188].
Clearly, the multifaceted capabilities summarized
here provide a strong rationale for a broader applica-
tion of mass spectrometry to the structure-function
investigation of nucleic acids. If the ever increasing
demands of the post-genomics age extend beyond the
need for mere sequence information, a new definition of
what can be considered as MS analysis of nucleic acids
should be formulated, which should include also the
analysis of their complexes with other biomolecules,
physiologic ligands, and xenobiotics. In many cases, the
physical-chemical characteristics and structural stabil-
ity of these functional assemblies are still largely deter-
mined by the nucleic acid components, even when such
components amount to only a small fraction of the
entire complex under investigation. In the case of pro-
tein-nucleic acid conjugates, for example, a high density
of negatively-charged phosphates may affect the overall
charge balance and may become a critical factor in the
selection of polarity and mode of operation. A higher
propensity to form cation adducts may command the
adoption of protocols for sample preparation, which are
more commonly associated with analytes of purely
nucleic acid nature. For these reasons, while the protein
moiety could still be perceived as the critical compo-
nent according to strict functional considerations,
analytical considerations could make the nucleic acid
moiety the focus of attention, due to the more strin-
gent requirements imposed on the MS analysis. Of-
ten, what we call “substrate” or “ligand” becomes a
question of perspective.
Now, if the range of information accessible by MS-
based technologies is so astonishingly wide, then why
isn’t their application more popular in the broader life
sciences community? Part of the answer may be found
in the intrinsic technical challenges posed by these
types of experiments, which may require know-how
that has yet to spread beyond a few dedicated labora-
tories. However, the progressive refinement of these
technologies, the streamlining of experimental strate-
gies, the complementary capabilities and advantages
over established methodologies, as well as the nearly
capillary diffusion of MS instrumentation, should con-
tribute to a considerable expansion in coming years.
Part of the answer may be found in the actual size of the
public engaged in this field of research, which is still a
small portion of the broader life sciences community
and includes only a handful of commercial enterprises
with a continued stake in nucleic acids. After all, the
proportion of nucleic acid-targeted drugs in the market
is miniscule in comparison with that of protein-targetedtherapeutics. However, with less than 1.5% of the
human genome coding for proteins, the potential for
discovering viable targets among the remaining transcribed
elements is too large to be ignored. MS-technologies will be
expected to play a very significant role in the exploration
of this extensive druggable space, supporting tradi-
tional tasks in drug discovery, as well as new strategies
for the identification of possible targets and therapeutic
candidates. When antisense and gene silencing technol-
ogies will overcome the last remaining hurdles that
hamper their widespread introduction in human ther-
apy, MS will be uniquely placed to accomplish the
operations required by manufacturing and regulatory
monitoring. Combined with new applications to funda-
mental biological studies, the activities spurred by the
changing demands of a rapidly developing field will
help redefine the evolving role of MS analysis of nucleic
acids in the post-genomics age.
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